CYP2C19

CYP2C19
Available structures
PDBHuman UniProt search: PDBe RCSB
Identifiers
AliasesCYP2C19, CPCJ, CYP2C, CYPIIC17, CYPIIC19, P450C2C, P450IIC19, cytochrome P450 family 2 subfamily C member 19
External IDsOMIM: 124020; HomoloGene: 133565; GeneCards: CYP2C19; OMA:CYP2C19 - orthologs
EC number1.14.14.51
Orthologs
SpeciesHumanMouse
Entrez

1557

n/a

Ensembl

ENSG00000165841

n/a

UniProt

P33261

n/a

RefSeq (mRNA)

NM_000769

n/a

RefSeq (protein)

NP_000760

n/a

Location (UCSC)Chr 10: 94.76 – 94.86 Mbn/a
PubMed searchn/a
Wikidata
View/Edit Human

Cytochrome P450 2C19 (abbreviated CYP2C19) is an enzyme protein. It is a member of the CYP2C subfamily of the cytochrome P450 mixed-function oxidase system. This subfamily includes enzymes that catalyze metabolism of xenobiotics, including some proton pump inhibitors and antiepileptic drugs. In humans, it is the CYP2C19 gene that encodes the CYP2C19 protein. CYP2C19 is a liver enzyme that acts on at least 10% of drugs in current clinical use, most notably the antiplatelet treatment clopidogrel (Plavix), drugs that treat pain associated with ulcers, such as omeprazole, antiseizure drugs such as mephenytoin, the antimalarial proguanil, and the anxiolytic diazepam.

CYP2C19 has been annotated as (R)-limonene 6-monooxygenase and (S)-limonene 6-monooxygenase in UniProt.